Results 71 to 80 of about 21,222 (210)

Treatment options for seasonal allergic rhinitis [PDF]

Primary Care Respiratory Journal, 2003
Seasonal Allergic Rhinitis (SAR) or ‘hay fever’ is a common, complex disorder resulting in nasal and ocular symptoms. Treatments for SAR aim to minimise symptoms, improve quality of life and reduce the risk of developing any co-existent disease. Improving the evidence-base for treatment decisions in primary care is now a priority for the NHS.
openaire   +1 more source

Assessment of oral allergy syndrome in patients with seasonal allergic rhinitis by food challenge test

Iranian South Medical Journal, 2014
Background: Oral allergy syndrome (OAS) characterized by oral IgE-mediated symptoms, which is caused by cross-reactivity between proteins in pollens, fresh fruit and vegetables. OAS is presents in 40% to 80% of Allergic rhinitis patients.
Farahzad Jabbari Azad, Afshin Shirkani, Reza Faridhosseini   +2 more
doaj  

Chronological changes in rhinitis symptoms present in school-aged children with allergic sensitization.

PLoS ONE, 2019
IntroductionIt is difficult to accurately predict the natural course of allergic rhinitis (AR), because it is affected by a wide variety of environmental influences, as well as genetic predisposition.
Michelle J Suh, Jin A Park, Suk Won Chang, Jeong Hong Kim, Keun-Hwa Lee, Seong-Chul Hong, Hye-Sook Lee, Ju Wan Kang   +7 more
doaj   +1 more source

Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis

Allergology International, 2018
Background: The emedastine patch was developed in Japan as the first transdermal drug delivery system of emedastine difumarate for allergic rhinitis.
Kimihiro Okubo, Eiji Uchida, Takaaki Terahara, Katsuhiko Akiyama, Shigeo Kobayashi, Yusuke Tanaka   +5 more
doaj   +1 more source

Fexofenadine is Efficacious and Safe in Children (Aged 6-11 Years) with Seasonal Allergic Rhinitis [PDF]

, 2003
Background: This is the first prospective, randomized, doubleblind, placebo-controlled study showing statistical improvement of an H1-antihistamine in children with seasonal allergic rhinitis in all symptoms throughout the entire treatment period ...
Bachert, C, Baena-Cagnani, C, Decosta, P, Finn, A, Hedlin, G, Kowalski, M, Meltzer, E, Potter, P, Rosado-Pinto, J, Ruuth, E, Scheinmann, P, Simons, F, Wahn, U   +12 more
core  

Online public concern about allergic rhinitis and its association with COVID-19 and air quality in China: an informative epidemiological study using Baidu index

BMC Public Health
Background Allergic rhinitis is a common health concern that affects quality of life. This study aims to examine the online search trends of allergic rhinitis in China before and after the COVID-19 epidemic and to explore the association between the ...
Yi Yu, Qinzhun Zhang, Xinmeng Yao, Jinghua Wu, Jialu He, Yinan He, Huaqiang Jiang, Dongxin Lu, Chengyin Ye   +8 more
doaj   +1 more source

At-a-glance - Pollens, climate and allergies: Quebec initiatives

Health Promotion and Chronic Disease Prevention in Canada, 2019
Pollen allergies are a major source of seasonal allergic rhinitis in North America. This type of rhinitis affects 17% of adults in Quebec, a marked increase in the last 30 years. Ragweed (Ambrosia artemisiifolia L.) pollens are responsible for 50% to 90%
Isabelle Demers, Pierre Gosselin
doaj   +1 more source

Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age [PDF]

Exploration of Asthma & Allergy
Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults.
Alberto Vidal, Pedro Cortez
doaj   +1 more source